Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hemant Murthy

BMT · Mayo Clinic Florida

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Pavlos Msaouel

GU Oncology · MD Anderson Cancer Center

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JFDr. Joshua Fein

    Dr. Joshua Fein

    Hematology & Oncology · Bone Marrow Transplant (BMT)
    Weill Cornell Medicine
    joshuaf

    Research

    Microbiome-based prediction of allogeneic hematopoietic stem cell transplantation outcome

    2025

    Via Genome Medicine

    Research

    Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation

    2025

    Via Blood Advances

    Research

    Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis

    2025

    Via Transplantation and Cellular Therapy

    Research

    Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study

    2025

    Via Bone Marrow Transplantation

    Research

    An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma

    2025

    Via Nature Medicine

    Research

    Age 60 or older is an independent predictor of outcomes after thiotepa-based autologous transplant in primary CNS lymphoma: a CIBMTR analysis

    2025

    Via Bone Marrow Transplantation

    Research

    Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study

    2024

    Via Bone Marrow Transplantation

    Research

    Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML

    2024

    Via Blood Advances

    Research

    Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile

    2024

    Via British Journal of Haematology

    Research

    CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma

    2024

    Via Blood Advances

    Research

    The sum of the parts: what we can and cannot learn from comorbidity scores in allogeneic transplantation

    2023

    Via Hematology, American Society of Hematology Education Program

    Research

    Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study

    2023

    Via Blood Advances

    Research

    A Simplified Comorbidity Index to Predict Nonrelapse Mortality in Allogeneic Hematopoietic Cell Transplantation

    2022

    Via Blood Advances

    Research

    Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma

    2022

    Via Transplantation and Cellular Therapy

    Research

    Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma

    2022

    Via Transplantation and Cellular Therapy